These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 21834778)

  • 1. Recent advances and patents in solid dispersion technology.
    Iqbal B; Ali A; Ali J; Baboota S; Gupta S; Dang S; Shadab M; Sahni JK
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):244-64. PubMed ID: 21834778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations.
    Srinarong P; de Waard H; Frijlink HW; Hinrichs WL
    Expert Opin Drug Deliv; 2011 Sep; 8(9):1121-40. PubMed ID: 21722000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubilization of poorly water-soluble drugs using solid dispersions.
    Tran TT; Tran PH; Khanh TN; Van TV; Lee BJ
    Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):122-33. PubMed ID: 23244679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Overview on Recent Patents and Technologies on Solid Dispersion.
    Kaushik R; Budhwar V; Kaushik D
    Recent Pat Drug Deliv Formul; 2020; 14(1):63-74. PubMed ID: 31951172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical solid dispersion technology: a strategy to improve dissolution of poorly water-soluble drugs.
    Kumar S; Gupta SK
    Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):111-21. PubMed ID: 23331062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosage form designs for the controlled drug release of solid dispersions.
    Tran PHL; Tran TTD
    Int J Pharm; 2020 May; 581():119274. PubMed ID: 32234566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCS class IV drugs: Highly notorious candidates for formulation development.
    Ghadi R; Dand N
    J Control Release; 2017 Feb; 248():71-95. PubMed ID: 28088572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral fast-release solid dispersion-paradigm shift to nanoparticles.
    Wong TW
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):227-43. PubMed ID: 21834774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
    Meng F; Gala U; Chauhan H
    Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid dispersions: a review.
    Dhirendra K; Lewis S; Udupa N; Atin K
    Pak J Pharm Sci; 2009 Apr; 22(2):234-46. PubMed ID: 19339238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.
    Vo CL; Park C; Lee BJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):799-813. PubMed ID: 24056053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release systems containing solid dispersions: strategies and mechanisms.
    Tran PH; Tran TT; Park JB; Lee BJ
    Pharm Res; 2011 Oct; 28(10):2353-78. PubMed ID: 21553168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug carrier systems for solubility enhancement of BCS class II drugs: a critical review.
    Kumar S; Bhargava D; Thakkar A; Arora S
    Crit Rev Ther Drug Carrier Syst; 2013; 30(3):217-56. PubMed ID: 23614647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on Strategies Using Swellable Polymers in Solid Dispersions for Controlled Drug Release.
    Tran TTD; Tran PHL
    Curr Pharm Des; 2017; 23(11):1639-1648. PubMed ID: 27774901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of poorly soluble compounds by amorphous solid dispersions.
    Lee TW; Boersen NA; Hui HW; Chow SF; Wan KY; Chow AH
    Curr Pharm Des; 2014; 20(3):303-24. PubMed ID: 23651395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
    Bikiaris DN
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1501-19. PubMed ID: 21919807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of solid dispersion-microsphere controlled release system for poorly water-soluble drug.
    Malipeddi VR; Dua K; Awasthi R
    Drug Deliv Transl Res; 2016 Oct; 6(5):540-50. PubMed ID: 27343081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.
    Baghel S; Cathcart H; O'Reilly NJ
    J Pharm Sci; 2016 Sep; 105(9):2527-2544. PubMed ID: 26886314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid dispersion technology as a strategy to improve the bioavailability of poorly soluble drugs.
    Cid AG; Simonazzi A; Palma SD; Bermúdez JM
    Ther Deliv; 2019 Jun; 10(6):363-382. PubMed ID: 31094298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Solid Dispersion Technology for Efficient Delivery of Poorly Water-Soluble Drugs.
    Paudwal G; Rawat N; Gupta R; Baldi A; Singh G; Gupta PN
    Curr Pharm Des; 2019; 25(13):1524-1535. PubMed ID: 31258070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.